State University of Ghent
Tube model facilitates assessment of central venous catheter performance
Published in Pharma Law Weekly, August 24th, 2004
"Central venous catheters are widely used as a hemoaccess method for dialysis therapy," scientists in Belgium explained.
In a study conducted by G. Mareels and colleagues at the State University of Ghent, the "performance parameters (velocities, pressure drop, shear rates, access recirculation) of the Niagara catheter" were "analyzed using computational fluid dynamics."
"Side holes are left open, closed, or reduced in size to assess the influence of this design feature," the collaborators noted. "Initially the catheter is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2004-08-24)
More Articles from Pharma Law Weekly
- Abgenix, Inc.
Biotech company reports quarterly loss of $0.76 per share - American Bio Medica Corporation
Biotech company granted patents related to fluid sample device - American HomePatient, Inc.
Home care firm calls for action to protect access to respiratory medication - Aon Consulting
Firm offers advice on new CMS guidance on retiree drug coverage - Apria Healthcare Group, Inc.
Apria comments on proposed reimbursement for inhalation drugs - Association of Community Cancer Centers
Reductions in Medicare payment for drugs could impact continuum of cancer care - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
